Late Breaking Abstract - Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort.
J. Anderson (Birtinya, Australia), E. Lau (Sydney, Australia), M. Lavender (Perth, Australia), R. Benza (Pittsburgh, United States of America), D. Celermajer (Sydney, Australia), N. Collins (Newcastle, Australia), C. Corrigan (Sydney, Australia), N. Dwyer (Hobart, Australia), J. Feenstra (Brisbane, Australia), M. Horrigan (Melbourne, Australia), D. Keating (Melbourne, Australia), E. Kotlyar (Sydney, Australia), T. Mcwilliams (Auckland, New Zealand), B. Rhodes (Christchurch, New Zealand), P. Steele (Adelaide, Australia), V. Thakkar (Liverpool, Australia), T. Williams (Melbourne, Australia), H. Whitford (Melbourne, Australia), K. Whyte (Auckland, New Zealand), R. Weintraub (Melbourne, Australia), J. Wrobel (Perth, Australia), A. Keogh (Sydney, Australia), G. Strange (Fremantle, Australia)
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Anderson (Birtinya, Australia), E. Lau (Sydney, Australia), M. Lavender (Perth, Australia), R. Benza (Pittsburgh, United States of America), D. Celermajer (Sydney, Australia), N. Collins (Newcastle, Australia), C. Corrigan (Sydney, Australia), N. Dwyer (Hobart, Australia), J. Feenstra (Brisbane, Australia), M. Horrigan (Melbourne, Australia), D. Keating (Melbourne, Australia), E. Kotlyar (Sydney, Australia), T. Mcwilliams (Auckland, New Zealand), B. Rhodes (Christchurch, New Zealand), P. Steele (Adelaide, Australia), V. Thakkar (Liverpool, Australia), T. Williams (Melbourne, Australia), H. Whitford (Melbourne, Australia), K. Whyte (Auckland, New Zealand), R. Weintraub (Melbourne, Australia), J. Wrobel (Perth, Australia), A. Keogh (Sydney, Australia), G. Strange (Fremantle, Australia). Late Breaking Abstract - Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort.. 495
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020
Impact of Improved Cookstove Usage on Lung Function in Congolese Refugees: A Prospective Cohort Study. Source: International Congress 2017 – The air indoor air pollution Year: 2017
Increased Risk of Heart Failure In Patients of Bronchiectasis – A Nationwide Population-Based Study Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019
Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity Source: International Congress 2019 – Bronchiectasis Year: 2019
Incidence of Cardiac Complications after Hospitalisation for Community Acquired Pneumonia: A Large Population-based Cohort Study Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020
The Disease Burden of Bronchiectasis in Korea: A National Database Study Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019
Post-Tuberculosis Bronchiectasis in India:Outcomes of the Indian EMBARC Registry Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges Year: 2018
Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT) Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021
COPD as a Risk Factor in Primary Care: A Canadian Retrospective Cohort Study Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Real World Effects of Medications for COPD - a UK Population-Based Non-Interventional Cohort Study With Validation Against Randomised Trial Results Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019
A Multidisciplinary Multicenter Study Evaluating Risk Factors, Prevalence and Characteristics of Post-COvid-19 Interstitial Lung Syndrome (PCOILS) Source: Virtual Congress 2021 – Imaging Year: 2021
Phenotyping Adults with Non-Cystic Fibrosis Bronchiectasis:A 5-Year Cohort Study in a Azerbaijan medical University Center Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017
Association Between Pain Level and Fatigue Level with Activities of Daily Living in Lung Cancer Patients Receiving Inpatient Cancer Therapy: A Pilot Study Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease Year: 2020
Late Breaking Abstract - NORdic Database for aSThmA Research (NORDSTAR): Swedish and Finnish patients Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors Year: 2018
Risk Score for Subclinical COPD: The NHLBI Pooled Cohorts Study Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020
ISHLT Registry Data and Country Registries: Comparison of reported European Lung Transplant Activities in 2016 Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019
Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
Severe Pulmonary Hypertension Management Across Europe (PHAROS): an ERS Clinical Research Collaboration Source: Eur Respir J, 55 (5) 2001047; 10.1183/13993003.01047-2020 Year: 2020
Influence of Smoking, Environmental Factors and Life Style on Lung Function in a Large German Cohort Source: International Congress 2018 – Occupational and environmental lung diseases: inhaled air quality and health effects Year: 2018
Evaluation of COPD Patient’s Relatives Assessment of Disease Awarness, Load of Care Giving and Loss of Workforce: Turkish Thoracic Society COPD Working Group. Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018